Financial Services Health Plans & Managed Care Managed Care Programs

Care Management

Multi-stakeholder benefits decisions where employer groups, brokers, and members must align on coverage and cost.

Casenet Netsmart Evolent Health Signify Health
Inside this journey
  1. Pre-Discovery

    Align the room on outcomes, decision process, and constraints before deeper discovery.

    1. Stakeholder Alignment

      Confirm decision roles (VP care mgmt., CMO, CIO, finance), timeline, success metrics, and audit readiness constraints.

      Alignment Questions

      Quick hello — who are we partnering with?

      • Who will be our primary day-to-day contact for this initiative (role & name if known)? Options: VP, Care Management, Chief Nursing Officer, Director, Care Management, Clinical Program Manager, IT Integration Lead, Other (please specify)
      • How urgent is this initiative on a scale from “monitoring” to “mission-critical” for your team right now? Options: Mission‑critical — immediate action required, High priority — within 30–90 days, Medium priority — this quarter, Lower priority — 6–12 months
      • In one sentence, how would your team describe the primary goal we should be solving together?
      • When you think about your care managers today, what single frustration do they mention first (e.g., caseload, documentation time, alert noise)?
      • Which existing vendors, internal teams, or legacy tools are already involved in care management today? Options: EHR (Epic/Cerner/Allscripts), Claims platform, Analytics vendor, Existing case management system, Outreach/IVR vendor, No external vendors, Other

      Who's actually holding the pen on decisions?

      • Who must give final approval to purchase and/or deploy a new care management platform — and who could veto it? Options: VP Care Management, CMO/Medical Director, CIO/IT, Chief Nursing Officer, Finance/CFO, Compliance/Legal, Procurement, Other
      • How do those decision-makers typically reach a decision — single approver, executive committee, or consensus across stakeholders? Options: Single approver, Executive committee, Consensus across multiple leaders, Procurement-led panel, Unclear / varies
      • For each of the roles you selected, what does success look like to them? Please list role → top outcome or concern.
      • Who outside of leadership (e.g., frontline nurses, utilization managers) will need to be convinced, and how do they usually express resistance? Options: Frontline nurses/care managers, Utilization review team, Provider partners, Quality/PI team, No frontline resistance expected, Other
      • How do decisions get escalated when a pilot or vendor isn’t meeting expectations (timeline, SLA, outcomes)? Options: Immediate exec review, Operational remediation plan, Contract negotiation, Pause/stop pilot, We don’t have a clear escalation path

      If this doesn’t move the needle, who feels the pressure?

      • Whose performance, budget, or contract renewal is most exposed if avoidable ED visits and PMPM don’t improve? Options: VP Care Management, Chief Nursing Officer, CMO, Finance/CFO, Provider network leadership, Other
      • Which measurable KPIs are non-negotiable for your team to consider this initiative successful within 6–12 months? Options: % reduction in avoidable ED visits, PMPM cost reduction, NCQA readiness/score improvement, HEDIS/utilization metrics, Clinician adoption/engagement, Member experience (Satisfaction)
      • Please provide current baseline values (or best estimates) for the top 3 KPIs you selected above.
      • What PMPM reduction target (approximate %) would satisfy finance in a 12‑month window? Options: >10%, 7–10%, 4–6%, 1–3%, No explicit target defined
      • Who will be responsible for validating the financial outcomes (role/team)? Options: Finance/CFO, VP Care Management, Value-based contracting team, Third‑party actuary, Other

      Audit day: could you pass right now?

      • If an NCQA or state audit happened this week, which of these artifacts are ready and easily exportable? Options: Care manager caseload lists with timestamps, Documented clinical protocols, Training logs and competencies, Member outreach logs (calls/texts), ADT/claims intake logs, We do not have audit‑ready artifacts
      • What’s the single biggest compliance or audit concern that keeps leadership up at night?
      • Have you had any recent findings, notices, or corrective actions related to care management quality or audits? Options: Yes — corrective action required, Yes — minor findings, No, Unsure
      • What specific evidence would satisfy auditors that your care management workflows meet contractual and NCQA standards?
      • Who owns audit readiness and how many dedicated FTEs or hours per month can they commit to preparing artifacts? Options: Compliance lead, Quality/improvement team, Care management ops, No dedicated owner / shared responsibility

      Data flows and integrations — where do projects actually get stuck?

      • If our engineers can’t get reliable access to ADT/claims/EHR data in the first 30 days, will the project pause or proceed with a reduced scope? Options: Pause until full data access, Proceed with reduced scope/pilot, Use synthetic/sample data until live feeds, Unsure
      • Which of these data feeds are live or easily accessible today? Options: Real‑time ADT, Daily claims, Pharmacy claims, Lab results, SDOH screening data, EHR clinical notes, None / limited access
      • Which systems/platforms are primary for your providers and payers (check all that apply)? Options: Epic, Cerner/Oracle, Allscripts, In-house EHR, Vendor claims platform (specify below), Other
      • Do you have sample files, data dictionaries, or existing API specs we can review during technical kickoff? Options: Full documentation available, Partial / some examples, No documentation available
      • What security, hosting, or legal constraints must we meet before connections are approved (e.g., on‑prem only, SOC2, BAAs)? Options: SOC2 Type II, HIPAA BAA required, On‑prem only / no cloud, Private network / VPN, State-specific security rules, Other
      • Who owns integrations on your side and what SLA can they meet for development and testing?

      Timeline pressure — perfect vs practical.

      • If everything lined up today, when do you need measurable improvement to influence contract renewals or audits? Options: Immediate (within 30 days), Within 3 months, Within 6 months, Within 12 months, No specific deadline
      • Is there an RFP or procurement milestone we must align with (date or window)? Options: RFP open/near (≤30 days), This quarter, Next quarter, 6–12 months, No RFP planned
      • What pilot length and cohort size would your team consider sufficient to make a go/no‑go recommendation? Options: 4–8 weeks, small cohort (50–200), 3 months, medium cohort (200–1,000), 6 months, larger cohort (1,000+), Depends on metrics agreed
      • Which internal gating milestones most often delay projects of this type? Options: Legal/BAA signoff, Data access approvals, Budget approval, Provider engagement / contracts, Clinician training availability, Other
      • How much flexibility does procurement/finance have to approve phased commercial terms (pilot → scale)? Options: Highly flexible, Some flexibility with executive buy‑in, Fixed terms only, Unsure / varies

      What would make you say yes — the deal clincher?

      • What’s the single, non‑negotiable piece of evidence or guarantee you’d need to greenlight this platform?
      • Which acceptance criteria must be demonstrably met at pilot completion for you to recommend scale? Options: Configured clinical workflows signed off, End‑to‑end live data integrations, Clinician adoption / task completion rate threshold, Observed reduction in ED visits vs baseline, NCQA artifact package ready, Financial validation of PMPM improvement
      • What clinician adoption metric would feel like a success (e.g., % of care managers using the workspace daily)? Options: >90%, 75–90%, 50–74%, <50%, Unsure / qualitative only
      • Who needs to be at the final commercial decision meeting? Options: VP Care Management, CMO/Medical Director, CIO/IT, Finance/CFO, Procurement, Compliance/Legal, Other
      • What would be the ideal next artifact or step from us to help you move toward a decision (pick all that apply)? Options: Pilot plan & SOW, Data mapping template, ROI / PMPM model, NCQA audit checklist, Demo with your live sample data, Reference customer call
      • Before we wrap up, what are you most afraid will go wrong if you pursue this change?
    2. Current State Mapping

      Document existing care management workflows, data sources, caseloads, and failure modes driving avoidable ED use.

      Current State

      Quick Snapshot: Where Are You Today?

      • In one short sentence, how would you describe the single biggest thing keeping your care management team from preventing avoidable ED visits today?
      • Which of these pressures feels most urgent to leadership right now? Options: Rising avoidable ED visits, PMPM cost overruns, NCQA / audit readiness, Clinician burnout / caseloads, Provider integration delays, Other
      • What is the typical RN care manager caseload (median or most common range)? Options: <30, 30–49, 50–79, 80–99, 100+
      • On an average shift, how would you describe time split between documentation vs member outreach? Options: Mostly documentation (>60%), About even (40–60%), Mostly outreach (>60%), Highly variable day‑to‑day
      • When did your avoidable ED rate begin to rise and what pattern have you seen since (steady, seasonal, cohort-driven)?

      If We Keep Quiet About This, What Breaks Next?

      • If the current approach continues for the next 6–12 months, what will be the most painful operational or financial consequence?
      • Which of these drivers do you believe is the primary upstream cause of the avoidable ED increases? Options: Poor post-discharge follow-up, Lack of SDOH support (housing/transportation), Medication non-adherence, Missed primary care access, Behavioral health crises, Risk stratification misses, Other
      • Which member cohorts are disproportionately contributing to avoidable ED visits? Options: Top 1% utilizers, Top 5% chronic complex, Serious mental illness, Substance use disorder, Dual eligibles, High social risk (SDOH)
      • How predictable are spikes in ED use (we can forecast them vs they feel random)? Options: Highly predictable, Somewhat predictable, Unpredictable, We haven't tried to forecast
      • How quickly can your team currently deploy an outreach intervention to a flagged high-risk member (from signal to completed outreach)? Options: Same day, 1–3 days, 4–7 days, More than a week, Not tracked

      Who Actually Owns the Decisions and the Day-to-Day?

      • Who in your organization loses the most sleep when avoidable EDs rise—whose job title changes if this keeps happening?
      • Which stakeholders must align to change a clinical workflow (select all who need to sign off)? Options: VP Care Management, Chief Medical Officer (CMO), CIO/IT, Finance, Chief Nursing Officer, Utilization Management Lead, Provider network leadership, Other
      • Who is the operational owner for day‑to‑day care manager tooling and who is the executive sponsor for program outcomes?
      • How aligned are the VP Care Mgmt, CMO, CIO and Finance on timeline and measurable targets for improvement? Options: Tightly aligned — shared targets and timeline, Mostly aligned but some disagreements, Major misalignment on priorities, We haven't had that discussion
      • Who will be our primary point of contact for discovery and for data/integration discussions?

      Hidden Data, Missing Signals — Where Things Go Dark

      • Tell us about the last time a patient ‘fell through the cracks’ because a feed, alert, or data point failed to arrive—what happened?
      • Which of these data sources do you currently receive and how reliable are they? Options: Real‑time ADT (reliable), Real‑time ADT (intermittent), Claims (daily/near‑real‑time), Claims (delayed batch), EHR CCD/C-CDA, Pharmacy claims, Labs, SDOH screening data, Provider outreach notes, None of the above
      • Do you have a consistent unique identifier linking claims, ADT and EHR (e.g., member ID matched across systems)? Options: Yes — one canonical ID, Partially — matches for some feeds, No — matching is manual or missing, Unsure
      • How often do you receive ADT alerts today? Options: Real‑time streaming, Near real‑time (minutes–hours), Daily batch, Irregular batches, Not currently receiving ADT
      • About what percent of your active population has usable SDOH screening data attached to their profile? Options: 0–10%, 11–25%, 26–50%, 51–75%, 76–100%, We do not track this

      A Day in the Life of Your Care Manager (Be Honest)

      • If an outsider watched a care manager for a day, what would surprise them most about how work actually gets done?
      • Which of these tasks occupy the largest slice of a care manager’s time? (select top 3) Options: Documentation/charting, Outbound outreach (calls/text), Care plan updates, Coordinating transportation/social supports, Prior auth/UM tasks, Data reconciliation/lookup, Inbox/fax processing, Other
      • Which tools/systems do care managers toggle between most frequently? Options: EHR, Claims portal, ADT viewer, Legacy case management system, Excel trackers, Fax/phone, Secure messaging, Our platform (if applicable), Other
      • How many separate systems does a care manager typically need to touch to complete a single outreach workflow (estimate)? Options: 1, 2, 3, 4+, Varies widely
      • What single manual handoff or task creates the most delays in closing care gaps?

      Failure Modes That Actually Cost You Money

      • Which recurring failure mode would you point to if someone asked: ‘Where are we literally wasting dollars?’
      • Which of these failure modes drive avoidable ED use in your population? Options: No timely post‑discharge contact, Missed medication reconciliation, Inaccurate risk stratification, Lack of transportation to follow‑up, Behavioral health escalation unmanaged, Provider access delays, Other
      • How often do those failures occur for the highest‑risk cohort (approx % of cases)? Options: <10%, 10–25%, 26–50%, 51–75%, 76–100%, We don't track this
      • When a failure occurs, how is it typically discovered (claims review, member complaint, clinician chart review, audit)? Options: Claims/retrospective review, Real‑time ADT/alerts, Member or provider complaint, Routine chart audits, We rarely discover failures systematically
      • Do you currently run root‑cause analyses and store lessons learned so the same failure doesn’t recur? Options: Yes, consistently documented, Occasionally, Rarely, Never

      Audit Day: Can You Produce the Paper Trail?

      • If an auditor requested evidence of timely follow‑up and interventions for a sampled cohort, would you be confident in producing it within 48 hours? Options: Yes — fully confident, Somewhat — would take effort, No — would take weeks, We don't have auditable records
      • Which documentation elements are reliably captured today (select all that are consistently stored)? Options: Care plans, Contact attempts/logs, Risk stratification scores, Intervention details and outcomes, Referrals and closed‑loop confirmations, Consent and SDOH assessments
      • What percentage of charts would you estimate meet NCQA care management documentation standards today? Options: >90%, 70–90%, 50–69%, 30–49%, <30%, Unknown
      • How long would it take you to run member‑level reports linking interventions to outcomes for an audit (e.g., 12 months of interventions vs ED visits)? Options: <1 day, 1–3 days, 1–2 weeks, More than 2 weeks, Not possible currently
      • What specific documentation or systems gaps would most likely cause an audit finding?

      What Small Fix Would Feel Like a Miracle?

      • If one modest change could reduce avoidable EDs among your highest‑risk 10% by 20%, what change would you pick first?
      • Which of these interventions do you already have some evidence for within your organization? Options: Focused post‑discharge outreach, Automated ADT->workflow routing, SDOH navigation services, Medication reconciliation workflows, Behavioral health rapid response, None of the above
      • What quick wins could realistically be tested in a 60–90 day pilot?
      • What constraints would most likely prevent a fast pilot (select all that apply)? Options: Limited data access/integration, Security/privacy review timelines, Staff bandwidth, Contracting/commercial approval, Budget constraints, Provider engagement
      • Who internally would need to sign off to greenlight a 60–90 day pilot? Options: VP Care Management, CMO, CIO/IT, Finance, Compliance/Privacy, Operational sponsor (director), Other

      How We'll Measure Progress — Metrics That Matter

      • Are your current success metrics set up to be actionable (linked to workflows and roles) or mostly retrospective KPIs? Options: Actionable and tied to workflows, A mix of both, Mostly retrospective KPIs, We haven't defined clear metrics
      • Which outcome measures would you prioritize for a first pilot (select up to 3)? Options: Avoidable ED visits, PMPM cost, 30‑day readmissions, Care manager time saved, NCQA readiness score, Member satisfaction/engagement, HEDIS gap closure
      • What attribution window would your finance team accept to link intervention to cost impact? Options: 30 days, 60 days, 90 days, 180 days, 12 months
      • What is the minimum measurable percent improvement you would require to consider a pilot commercially viable? Options: >5%, 5–10%, 11–20%, >20%, Undecided / depends on cohort
      • Who will own ongoing measurement and reporting once a pilot moves to scale? Options: VP Care Management, Quality/Analytics team, Population Health team, Finance, Third‑party vendor, Other

      Next Smart Steps — Commitments, Risks, and Red Flags

      • What is the single biggest red flag that would make you stop a deployment in the first 90 days?
      • Which of the following must be in place before you consider a pilot (minimum set)? Options: Access to ADT feeds, Claims data for cohort definition, Identified pilot cohort, Operational owner and staff time, Security/BAA in place, Executive sponsorship
      • Do you have any fixed deadlines (RFP due date, NCQA audit, contract renewal) that would constrain our timeline? Options: Yes — specify dates below, No fixed deadlines, Unsure
      • What would meaningful progress look like at 30 / 90 / 180 days (one line each)?
      • Are you open to a focused 6–8 week discovery engagement that produces: prioritized failure modes, data map, pilot design, and a timeline? Options: Yes — ready to start, Maybe — need to confirm stakeholders, No — prefer a different approach
  2. Outcome Discovery

    Define target outcomes, measurable success signals (ED visits, PMPM, NCQA readiness), and attribution windows.

    Discovery Questions

    Starting with What Matters Most

    • To get started, which single outcome is the executive team most insistent we deliver in the next 6–12 months? Options: Reduce avoidable ED visits, Lower PMPM cost, Improve NCQA care management scores, Reduce nurse caseloads / documentation burden, Improve member experience / satisfaction, Other
    • How confident are you in the current baseline numbers for that outcome (e.g., current avoidable ED rate, current PMPM)? Options: Very confident — validated across data sources, Somewhat confident — estimated from limited data, Low confidence — no reliable baseline, Don't know
    • Please share the numeric baseline and the time period it covers (e.g., 'Avoidable ED: 15% increase year-over-year; baseline period Jan–Dec 2025')
    • Who in your org will be held accountable if that outcome isn’t achieved (role/title)? Options: VP Care Management, CMO, CIO, Head of Quality/NCQA lead, Finance lead, Other

    Are We Measuring the Right Things (or Just Measuring Busywork)?

    • If the metrics we're tracking today changed but member outcomes didn’t, what would that tell you about your current measurement approach? Options: We're tracking process not outcomes, We lack attribution between activity and outcomes, Metrics are noisy / not timely, We need clearer clinical acceptance criteria, Other
    • Which of these outcome signals matter most for your stakeholders? Select all that apply. Options: ED visits (avoidable / potentially preventable), PMPM cost, 30/90-day readmissions, NCQA care management readiness / scores, Member engagement / outreach response rate, Clinical escalation rates, Other
    • For each selected signal, what is the numerical target (e.g., % reduction or $ per member) and the timeframe you consider a success?
    • Which data sources do you currently trust to measure those signals in near-real time (pick all that you rely on today)? Options: Claims (lagged), Real-time ADT feeds, EHR clinical notes, Pharmacy claims, SDOH / screening tools, Lab results, Other
    • Where do you feel the biggest gap is between what you can measure and what you need to prove for an audit or NCQA review?

    Where the Bottlenecks Hide — Not the Ones You Tell Vendors About

    • If your care teams could snap their fingers and remove one recurring bottleneck that most reliably causes avoidable ED visits, what would it be?
    • How do current workflows or tools actively make clinical outreach slower, less precise, or less likely to reach the right members? Options: Manual trackers and spreadsheets, Delayed claims data, Fragmented alerts (ADT not integrated), High documentation burden, Poor risk stratification, Other
    • Tell us about a recent case where the workflow failed—what happened, and what was the downstream outcome?
    • How predictable is the caseload mix by acuity today (e.g., what % are high-acuity vs. moderate vs. low), and how often does that mix surprise your managers? Options: Highly predictable, Somewhat predictable, Often surprising, No visibility
    • What parts of the clinician experience (alerts, navigation, documentation) cause the most frustration or lead to workarounds?

    Who Really Owns Success (and What Will They Accept?)

    • If finance asks for a PMPM reduction of X within 12 months, what political, contractual, or program constraints could make that target unrealistic?
    • Which stakeholders must sign off on both the clinical approach and the measurement plan before you can proceed? Options: VP Care Management, CMO, CIO, Head of Quality/NCQA, Finance/FP&A, Legal/Compliance, Provider partners
    • What evidence would reassure the CMO that the platform’s protocols are clinically sound (e.g., peer‑reviewed studies, pilot results, clinical advisory letters)? Options: Peer-reviewed studies, Published case studies, Local pilot data, Clinical advisory board endorsement, NCQA/contractual mapping, Other
    • How will the CIO evaluate success from an integration perspective (e.g., percent of EHRs integrated, latency targets, data fidelity thresholds)?
    • Who will be the operational owner of measurement and reporting once outcomes are being tracked (title/role)? Options: VP Care Management, Head of Data/Analytics, Quality lead, Operations manager, Other

    What Would Success Actually Feel Like — Beyond the Numbers

    • Close your eyes and imagine 12 months after a successful deployment: what’s different in a typical care manager’s day?
    • How would members' experiences change in ways that matter for retention or contracted performance guarantees?
    • Which qualitative indicators would you use to prove to your board or payer that outcomes improved (e.g., fewer escalations, clinician satisfaction, audit readiness anecdotes)? Options: Clinician satisfaction scores, Anecdotal case studies, Provider partner testimonials, Reduction in member complaints, Other
    • What trade-offs would you tolerate to hit the target (for example: slower rollout, higher upfront cost, tighter clinical protocols)? Options: Slower rollout, Higher upfront investment, Tighter clinical protocols, Limited initial cohort, Other
    • What would make your team feel pride about the program—what non-financial win is equally persuasive?

    How Do We Know Change Is Attributable — Picking the Right Window

    • If we report a reduction in ED visits, what attribution window would your stakeholders consider credible (the period between intervention and measured impact)? Options: 30 days, 60 days, 90 days, 180 days, 12 months, Other
    • How do you currently handle attribution when multiple interventions or community partners are involved?
    • Are there contractual or regulatory windows (e.g., annual NCQA review cycles, state audits) that force a minimum or maximum attribution period? Options: Yes — fixed windows, No — flexible, Not sure
    • Would you be open to a mixed attribution model (short-term signal + longer-term trend) to balance quick wins and durable impact? Options: Yes, Maybe, need details, No

    Data Reality Check — Can We Measure What We Promise?

    • Which of these feeds are already live and reliable for your care teams today? Options: Real-time ADT, Daily/near-real-time claims, Pharmacy claims, EHR vitals/notes, SDOH screening results, Labs, None of the above / manual only
    • For feeds that are delayed or missing, what is the typical lag or blocker (e.g., vendor contracts, provider footprint, technical mapping)?
    • What level of data fidelity do you require to trust an outcome measure (e.g., member-level match rate, completeness threshold)? Options: >95% match, 90–95%, 80–90%, Lower acceptable if supplemented by clinical validation, No strict threshold
    • Which privacy, consent, or contract limitations could restrict how we use data for attribution or program measurement?
    • Would running a short, focused pilot with a single high-acuity cohort to validate data and attribution be acceptable to your stakeholders? Options: Yes — preferred, Maybe — depends on scope, No

    Risks We Should Name Out Loud

    • What are the three risks that keep you up at night about a technology-led care management program aimed at reducing ED use?
    • Which of those risks do you feel you have partial control over versus those you cannot control? Options: We control people/process, We control some integrations, We cannot control external provider behavior, We cannot control claims latency, Other
    • If a key risk materializes (e.g., model misidentifies members), what rapid mitigation would you expect us to execute?
    • How important is it for your team to see a risk‑reduction plan (roles, timelines, acceptance criteria) before you commit commercially? Options: Critical — must have, Helpful but not required, Neutral, Not necessary

    Decision Signals & Next Steps — What Would Make This a ‘Yes’?

    • What are the top three decision signals (e.g., specific pilot metrics, stakeholder approvals, security review pass) you need to say yes to a full deployment?
    • Which of those signals is the single gating item that, if missing, would stop the project? Options: Data access / feeds, CIO security sign-off, CMO clinical acceptance, Finance ROI threshold, Other
    • Realistically, what is your target decision date for committing to a pilot or contract? Options: Within 30 days, 30–60 days, 60–90 days, 3–6 months, Undecided
    • What support or artifacts would remove the last bit of hesitation (e.g., a week-long clinical workshop, a sample NCQA mapping, a data extract proof-of-concept)? Options: Clinical workshop, NCQA mapping document, Data POC with sample records, Pilot proposal with commercial terms, Other
    • Who else should we involve in the next conversation to move this forward, and what will they need to see?
  3. Solution Experience

    Walk through how the platform delivers the target outcomes using the plan’s real scenarios, dataflows, and clinician workflows.

    Experience Meetings

    • Solution Experience: Current State & Consequence Alignment
    • Solution Experience: Live Scenario Walkthrough (Customer Data)
    • Solution Experience: Clinician Workflow Role‑Play & Adoption Validation
    • Solution Experience: Dataflows, Integration Points & Security Proof
    • Solution Experience: Outcomes Measurement, Acceptance Criteria & Mutual Confirmation
    • Provide CIO with the security/compliance evidence required for internal approval.
    • Prove the platform can produce the future state outcomes for concrete member scenarios.
    • Tie every shown action to a specific consequence reduction agreed earlier.
    • Collect customer validation or corrections in real time to refine configuration.
    • List integration/data gaps requiring follow‑up with owners and timelines.
    • Vendor: Produce a walkthrough summary mapping each scenario step to the agreed acceptance criteria.
    • Customer IT: Confirm availability of live ADT and claims feeds for sandbox testing within timeline.
    • Clinical Lead: Provide feedback on workflow suggestions and any protocol edits within 5 business days.
    • Introductions & Adoption Objective
    • Confirm workflows are intuitive for frontline clinicians and reduce documented time compared to current tools.
    • Obtain explicit yes/no adoption signals and list required UX/configuration changes.
    • Agree frontline‑led mitigations for adoption risks and initial training cadence.
    • Vendor UX: Implement top 3 clinician requests in sandbox and deliver updated build for validation.
    • Customer: Identify 2 pilot nurse super‑users and schedule their train‑the‑trainer session.
    • Clinical Ops: Provide baseline documentation time metrics to measure post‑deployment improvement.
    • Integration Overview & Objectives
    • Agree an executable data integration plan with owners, timelines, and measurable integration tests.
    • Welcome & Objectives
    • Identify and assign mitigation actions for all identified data breakpoints.
    • CIO: Provide sample SFTP/HL7/CSV endpoints, schemas, and test credentials to vendor.
    • Vendor: Deliver an integration test plan with pass/fail criteria and schedule the first end‑to‑end run.
    • Security Officer: Share required compliance artifacts and timeline for SOC/HIPAA review.
    • Recap Proven Future State Elements
    • Agree a measurable outcomes plan with baselines, metrics, attribution windows, and sign‑off owners.
    • Set explicit numeric acceptance criteria that will govern deployment validation and commercial milestones.
    • Receive stakeholder confirmation to move into Solution Scope and Mutual Commit stages or list required conditions.
    • Vendor & Analytics Lead: Produce the outcomes measurement workbook with baselines and calculation methodology.
    • Finance: Confirm PMPM targets and any shared‑savings considerations to include in commercial negotiations.
    • Program Sponsor: Schedule the Solution Scope kickoff once acceptance criteria are signed.
    • Have a single, signed‑off current state statement everyone agrees is accurate.
    • Agree quantified consequences (PMPM, ED visits, audit exposure) tied to the problem.
    • Define a one‑sentence operational future state that will guide the solution proof points.
    • Confirm required sample data and records for the live solution walkthrough.
    • Customer: Deliver ED utilization extract, 3 anonymized member records, and caseload sample within 3 business days.
    • Vendor: Draft one‑sentence future state and circulate for stakeholder sign‑off.
    • Project Lead: Schedule the Scenario Walkthrough meeting and invite operational users.
    • Recap Objectives & Validation Criteria
    • Readback: One‑Sentence Current State
    • Role‑Play: Intake & Prioritization Flow
    • Walkthrough: Member Scenario A (High‑Risk ED Use)
    • Define Measurement Plan & Attribution Windows
    • Map Dataflows with Customer Systems
    • Consequence Quantification
    • Demonstrate Data Matching & Attribution
    • Set Acceptance Criteria & Gates
    • Measure Time & Steps (Proof)
    • Tie Steps Back to Consequence
    • Identify Integration Breakpoints & Mitigations
    • Validation Checkpoint
    • Role‑Play: Care Plan Update and Documentation
    • Define One‑Sentence Future State (Success Outcome)
    • Risk Adjustment & Statistical Considerations
    • Security & Compliance Walkthrough
    • Feedback & Rapid Iteration
    • Gap Mapping (Diagnosis)
    • Decision & Next Commercial Steps
    • Walkthrough: Member Scenario B (Care Transition Failure Mode)
    • Validation & Confirmation
    • Adoption Risks & Mitigations
    • Integration Acceptance Tests
  4. Solution Scope

    Define modules, configuration needs, integrations, clinical protocols, and measurable acceptance criteria.

    Scope Configuration

    • Ingest real-time ADT alerts
    • Integrate claims feed and normalize data
    • Connect provider EHRs via HL7/CCDA interfaces
    • Deploy predictive risk stratification model
    • Configure care manager workspace views and task lists
    • Activate automated member outreach (IVR/SMS/secure message)
    • Deploy SDOH screening forms and referral integration
    • Implement transition-of-care task bundles and workflows
    • Set up medication reconciliation data exchange
    • Configure utilization management rules engine
    • Deploy disease- and condition-specific care plan templates
    • Provision mobile care manager app and user access
    • Launch utilization and PMPM cost analytics dashboards
    • Deliver role-based care manager training sessions

    Scope Questions

    Ingest real-time ADT alerts

    • Do you currently receive ADT feeds from your provider network? Options: Yes, No, Partial (some providers)
    • Which ADT interface formats are available from your partners? Options: HL7 v2 (ADT), FHIR ADT, CCDA, Other / Vendor-specific
    • How many distinct hospital or facility sources will send ADT events? Options: 1-5, 6-20, 21-100, 100+
    • What is the expected daily ADT event volume (approx.)? Options: <50, 50-500, 500-2,000, >2,000
    • Which ADT event types do you need ingested and surfaced (select all that apply)? Options: Admit, Discharge, Transfer, Observation, ED visit, Clinical status update
    • What are your latency requirements for ADT events to appear in the care manager workspace? Options: Near real-time (<5 minutes), Within 15 minutes, Within 1 hour, Same day (batch)

    Integrate claims feed and normalize data

    • Are claims feeds available as batch files, near‑real‑time streams, or both? Options: Batch (daily/weekly), Near real-time (within 24 hrs), Real-time / streaming, Not available yet
    • Which claim formats do you support or expect (select all that apply)? Options: X12 837 (professional), X12 837 (institutional), 835 (remittance), CSV/Flat file, Other
    • Which claim-based fields must be normalized and available (e.g., paid amount, service dates, procedure codes)?
    • What is the acceptable data lag for claims used in risk stratification and PMPM analytics? Options: <7 days, <14 days, Monthly, Quarterly
    • Who will own mapping/ETL for claims field normalization (plan IT, vendor, third-party integrator)? Options: Plan IT, Vendor, Third-party integrator, Shared responsibility
    • What acceptance criteria do you require for normalized claims (e.g., match rate threshold, field-level completeness)? Options: >95% match/completeness, 90-95%, Custom threshold (describe below)

    Connect provider EHRs via HL7/CCDA interfaces

    • Which EHR vendors/systems must be connected? Options: Epic, Cerner/Millennium, Allscripts, Athenahealth, Other
    • Which interface types are available or required from providers? Options: HL7 v2 feeds, CCDA documents, FHIR APIs, Other / custom
    • How many distinct provider organizations/sites require integration? Options: 1-5, 6-20, 21-50, 50+
    • Which clinical documents or data elements must be ingested (e.g., progress notes, problem list, med list, lab results)?
    • Do you have signed data sharing agreements or HIE participation that permits EHR ingestion? Options: Yes, No, In progress
    • What testing and validation support will provider IT teams provide (test endpoints, sandbox data)? Options: Full testing support, Limited support, No support - vendor must coordinate

    Deploy predictive risk stratification model

    • What outcome horizon should the model predict (select primary)? Options: 30-day utilization, 90-day utilization, 12-month PMPM risk, Custom
    • Which data sources should feed the model? Options: Claims, ADT / encounter data, EHR clinical data, Pharmacy claims, SDOH / screenings, Other
    • What minimum model performance thresholds do you require (e.g., AUC, precision @ top decile)? Options: AUC > 0.75, AUC 0.7-0.75, Custom (describe), No formal threshold
    • How often should the model be retrained or recalibrated? Options: Monthly, Quarterly, Biannual, Annually, On-demand
    • Do you require explainability or feature-level reasoning for high-risk flags (for clinician review/audit)? Options: Yes - feature explanations required, No - score only, Partial - key drivers only
    • What acceptance criteria must be met before model-driven tasks are enabled (e.g., pilot with N members, validation against known cohort)?

    Configure care manager workspace views and task lists

    • Which user roles must have tailored workspace views (select all that apply)? Options: RN care manager, LPN/MA, Social worker, Utilization manager, Supervisor/leader
    • How should task lists be prioritized or grouped (risk score, ADT events, due date, custom tags)? Options: Risk score, ADT events, Due date / SLA, Assigned cohort, Custom
    • What typical caseload size per user should workspace defaults support (for filtering and paging)? Options: <50, 50-80, 80-150, 150+
    • What specific data elements or widgets must be visible on the primary member card (e.g., meds, recent ADT, outstanding tasks)?
    • Do you require role-based dashboards, audit logging, or supervisor escalation views? Options: Role-based dashboards, Audit logs, Supervisor escalation, All of the above
    • What acceptance criteria indicate the workspace is configured successfully (e.g., task completion rates, user satisfaction score)?

    Activate automated member outreach (IVR/SMS/secure message)

    • Which outreach channels do you want to enable initially? Options: IVR, SMS/Text, Secure message (portal), Email, Live call-back
    • Do members need to opt-in for digital channels (SMS/secure message) and are opt-in lists available? Options: Yes - opt-in required and list available, Yes - opt-in required but not available, No opt-in required, Unsure
    • Which languages must outreach support? Options: English, Spanish, Other (specify)
    • Do you have existing templates/consent language and content for outreach, or require vendor-provided templates? Options: We have templates, Require vendor templates, Hybrid
    • Are there regulatory/consent requirements to consider (e.g., TCPA for SMS, state Medicaid restrictions)? Options: Yes - list provided, Yes - but not documented, No
    • What escalation rules should apply after automated outreach (e.g., escalation to RN within 24 hrs if no response)?

    Deploy SDOH screening forms and referral integration

    • Which SDOH screening tool(s) do you plan to use (select all that apply)? Options: PRAPARE, AHC HRSN, Custom screening, Protocolized NCQA tool
    • Where should completed screenings be stored or referenced (EHR, care platform, separate SDOH system)? Options: EHR, Care management platform, SDOH partner/platform, Other
    • Do you require closed‑loop referrals to community partners and status tracking? Options: Yes - closed-loop required, No - referral only, Partial (pilot)
    • What referral partners and data exchange methods are available (API, secure email, vendor portal)?
    • What KPIs should SDOH workflows drive or report (screening completion rate, referral closure rate)?
    • What acceptance threshold do you expect for SDOH screening adoption in the pilot (e.g., 70% completion among targeted contacts)? Options: >80%, 70-80%, 50-70%, Custom

    Implement transition-of-care task bundles and workflows

    • Which transition scenarios must be covered by task bundles (select all that apply)? Options: Hospital discharge to home, SNF to home, ED to home, Post-procedure transitions
    • What core tasks should each bundle include (med reconciliation, 72-hr follow-up call, appointment scheduling)?
    • What SLA/timing requirements apply (e.g., follow-up call within 24/48/72 hours)? Options: 24 hours, 48 hours, 72 hours, Custom
    • Who owns each transition task (RN, social worker, care coordinator, delegated vendor)? Options: RN, Social worker, Care coordinator, Delegated vendor, Other
    • Do you require auto‑triggering of bundles from ADT events or manual assignment? Options: Auto-trigger from ADT, Manual assignment by user, Hybrid
    • What success metrics will validate transition workflows (reduced readmission, completed reconciliations, appointment kept)?

    Set up medication reconciliation data exchange

    • Which medication sources must be reconciled (EHR med list, pharmacy claims, PDMP, patient-reported)? Options: EHR med list, Pharmacy claims, PDMP, Patient-reported, Other
    • How frequently should reconciliation occur or be refreshed for a member? Options: On every ADT event, Daily, Weekly, On-demand/manual
    • What matching or deduplication logic do you require (rule-based, fuzzy matching, provider review)? Options: Exact match, Fuzzy matching with review, Rule-based + manual reconciliation
    • What workflow is expected when discrepancies are found (auto-update, flag to clinician, contact pharmacy)?
    • What acceptance criteria indicate medication reconciliation is functioning (e.g., % reconciled within 72 hours)? Options: >90% within SLA, 75-90% within SLA, Custom

    Configure utilization management rules engine

    • What types of UM rules do you need to implement initially (prior authorization, concurrent review, retrospective review)? Options: Prior authorization, Concurrent review, Retrospective review, Criteria for utilization alerts
    • What data triggers should evaluate rules (claims, ADT events, clinical thresholds, lab values)? Options: Claims, ADT events, EHR clinical data, Lab results, Other
    • Who will author and approve business rules (plan medical director, UM team, vendor)? Options: Plan medical director/CMO, UM team, Vendor, Third-party clinical advisory
    • Do rules require multi-step approvals or automatic auto-approvals for low-risk actions? Options: Multi-step approvals, Auto-approve low-risk, Hybrid
    • What audit and reporting capabilities are required for UM decisions (e.g., justification text, time stamps)? Options: Full audit trail, Basic logging, None
    • What acceptance testing will validate the rules engine before go-live (sample scenarios, pass/fail criteria)?

    Deploy disease- and condition-specific care plan templates

    • Which conditions should be prioritized for template deployment (select top 3)? Options: Congestive heart failure (CHF), Chronic obstructive pulmonary disease (COPD), Diabetes, Behavioral health, Complex multimorbidity
  5. Mutual Commit

    Finalize commercial terms, confirm responsibilities, data access commitments, and audit/NCQA readiness milestones.

    Agreement Modules

    • Statement of Work (SOW)
    • Master Services Agreement (MSA)
    • Commercial Terms & Pricing Schedule
    • Payment Schedule & Billing Terms
    • Data Use & Access Agreement (DUA/DPA)
    • Security & Compliance Attestation
    • Audit & NCQA Readiness Commitment
    • Integration & Data Feed Commitments
    • Roles, Responsibilities & RACI
    • Implementation Timeline & Go‑Live Plan
    • Acceptance Criteria & Outcome Measurement Plan
    • Training & Change Management Commitment
    • Service Level Agreement (SLA)
    • Change Order & Scope Adjustment Process
    • Governance, Escalation & Steering Committee Charter
    • Termination, Transition & Continuity Plan
    • Legal & Procurement Final Sign‑offs
  6. Deployment

    Operationalize rollout with readiness checks, enablement, and outcome validation.

    1. Pre-Deployment Readiness

      Verify data feeds, integrations, hosting, security, and clinician adoption risks are addressed before execution.

      Readiness Questions

      Start with Your Story

      • Tell us your role and the one-sentence reason you invited us to this conversation.
      • How long have you been accountable for care management at this plan? Options: Less than 1 year, 1–2 years, 3–5 years, 6–10 years, More than 10 years
      • Who are the key stakeholders we should be speaking with on this initiative (please list titles and their primary concern)?
      • What single event or metric change most clearly triggered urgency right now (e.g., ED visits up 15%, upcoming NCQA audit, contract renewal)? Options: Avoidable ED increase, Upcoming NCQA/contract audit, Rising PMPM costs, Provider escalation/complaints, Other
      • If you could capture how this situation feels to you in three words, what would they be?

      Are We Comfortable With 'Good Enough'?

      • If nothing changes, what does 'good enough' look like for your care management program in 12 months—and who will bear the consequences? Options: Stable workflows but rising costs, NCQA scores decline, Higher audit risk/penalties, Worse member outcomes/readmissions, Other
      • How has the 15% increase in avoidable ED visits translated into financial or contractual pressure for your team (examples, dollar estimates, or penalties)?
      • Which quality or contractual thresholds are you most worried about missing if performance doesn’t improve? Options: NCQA accreditation metrics, State Medicaid contract KPIs, HEDIS/Stars measures, Internal care management targets, Other
      • Who inside finance, legal, or executive leadership is actively asking about care management performance—how vocal are they and how often do they request updates? Options: Daily, Weekly, Monthly, Quarterly, Only on request
      • What would an unacceptable outcome look like to you—both operationally and politically—if we fail to reverse current trends?

      Where the Day Really Goes

      • Which single task consumes the most clinical time but produces the least measurable impact? Options: Clinical documentation, Manual data reconciliation, Outbound calling/logistics, Updating trackers/Excel, Prior authorization/phone tag, Other
      • On an average day, how many members does a nurse care manager actively manage (typical caseload)? Options: <20, 20–40, 41–60, 61–80, 81–100, >100
      • What percentage of a care manager’s time is spent on direct member outreach versus documentation and coordination? Options: >75% outreach, 50–75% outreach, 25–50% outreach, <25% outreach
      • Which workflows currently require manual cross-checking across multiple systems (give 1–3 concrete examples)?
      • Can you describe a recent member case where the current workflow failed to prevent an avoidable ED visit—what happened and why?

      What Keeps Your Clinicians Awake at Night?

      • If a new platform doesn’t make your clinicians’ lives measurably easier within 30 days, would leadership consider stopping the rollout? Options: Very likely, Somewhat likely, Unlikely, Depends on pilot results
      • What are the three most common frustrations nurses or care coordinators voice about your current tools or processes?
      • Tell us about prior technology rollouts—what worked, what failed, and what you learned about clinician adoption?
      • Which adoption levers have the most influence in your organization (e.g., incentives, protected time, clinical champions, mandatory training)? Options: Clinical champions, Incentives/bonuses, Protected workflow time, On-site coaching, Mandated compliance, Other
      • How do you measure clinician burden or burnout today (surveys, turnover, time-motion studies, other)? Options: Surveys, Turnover rates, Time-motion data, Anecdotal reports, Not measured

      What Success Actually Looks Like (Show Me the Money and the Metrics)

      • If finance asked for one number to justify this investment in 12 months, what single metric would close the deal for you? Options: PMPM reduction, Avoidable ED % reduction, Total cost of care reduction, NCQA readiness score, Return on Investment (ROI), Other
      • What is your target for that metric (specific percentage or dollar amount) and what is today’s baseline?
      • What attribution window do you consider fair for measuring impact (e.g., 30, 60, 90, 180 days) for avoidable ED and PMPM improvements? Options: 30 days, 60 days, 90 days, 180 days, Other
      • Beyond the headline metric, what operational indicators will tell you a rollout is on track (examples: outreach completion rate, risk stratification precision, closed-loop referrals)?
      • How confident are you in your current data and analytics to measure those outcomes reliably? Options: Highly confident, Somewhat confident, Low confidence, Not confident at all

      Data & Integration: Nightmare or Launchpad?

      • Which integration, if delayed or inaccurate, is most likely to derail deployment? Options: Claims feed, Real-time ADT alerts, EHR interoperability (read/write), Pharmacy/PDMP, Lab results, SDOH feeds, Other
      • Which data standards and transfer methods are your systems currently able to support out-of-the-box (select all that apply)? Options: FHIR APIs, HL7 v2, SFTP flat files, Custom APIs, CCDA, Other
      • Describe any legal, firewall, or vendor restrictions that typically slow down data sharing with third parties.
      • Do you have sample datasets or a sandbox environment we can use for end-to-end testing, and if so, what’s the process to request access? Options: Yes — immediate access, Yes — requires approvals, Planned but not ready, No sandbox available
      • What are your minimum acceptable data latency and completeness thresholds for real‑time alerts and claims ingestion? Options: Real-time (<1 hour), Near real-time (1–24 hours), Daily, Weekly

      Audit, Compliance, and NCQA — What’s at Stake?

      • If an auditor requested evidence of care management impact today, what could you produce immediately? Options: Case-level notes with outcomes, Aggregated reports by cohort, Limited manual samples, No reliable artifacts, Other
      • Have you had recent audit findings related to care management or documentation—if yes, what were the gaps called out? Options: Yes — documentation gaps, Yes — data/reporting gaps, Yes — process gaps, No recent findings, Not sure
      • What artifacts does leadership expect us to deliver to support NCQA readiness (examples: protocol adherence logs, staff training records, closed-loop referrals)?
      • Who in your organization is responsible for audit responses and NCQA evidence assembly (title/role)?
      • What timeline do you have to demonstrate audit/NCQA readiness (e.g., next 3 months, 6 months, by contract renewal)? Options: Immediately (0–3 months), 3–6 months, 6–12 months, More than 12 months

      What Would Make Us an Irreplaceable Partner?

      • What would make you say, at the end of this project, 'this vendor saved our renewal'? Options: Rapid measurable impact, Full audit readiness, Seamless clinician adoption, Flexible commercial terms, Strong data governance/support, Other
      • What commercial or contractual flexibilities would be most important to you (pilot pricing, milestone payments, SLAs, risk-sharing)? Options: Pilot pricing, Milestone-linked payments, Performance-based risk sharing, Standard licensing, Other
      • What operational responsibilities must your team retain versus what you expect the vendor to own during deployment?
      • Who are the decision-makers and approvers for contract sign-off and funding, and what cadence do they require for updates? Options: VP Care Management, CMO, CIO/CTO, Finance Director, General Counsel, Other
      • If we proposed a phased pilot for a high‑acuity cohort, what success criteria would make you ready to scale? Options: X% reduction in avoidable ED, Y PMPM savings, Clinician time saved per day, Successful data integrations, Positive clinician satisfaction
    2. Deployment Enablement

      Schedule tasks, train care teams, sequence phased rollout for high‑acuity cohorts, and assign operational owners.

    3. Validation Checklist

      Verify acceptance criteria, run end‑to‑end tests with live data, and confirm outcome measurement baselines.

      Validation Questions

      Start: Who You Are and What Keeps You Up at Night

      • Which best describes your role and primary responsibility for care management? Options: VP Care Management, Chief Nursing Officer, Director of Case Management, Clinical Operations Lead, Chief Medical Officer, CIO/IT leader, Finance/Actuarial, Other (please specify)
      • What is your top strategic priority for your care management program this 12-month cycle? Options: Reduce avoidable ED visits, Improve NCQA readiness, Reduce PMPM costs, Improve clinician capacity/adoption, Data/integration modernization, Other (please describe)
      • Which range best describes an average nurse care manager caseload today? Options: <40, 40–59, 60–79, 80–99, 100+
      • How many members are covered under the care management program we’d be discussing? Options: <5,000, 5,000–25,000, 25,001–100,000, 100,001–500,000, 500,001+
      • Which systems or tools are your care teams actively using today? (select all that apply) Options: Legacy case management software, EHR/Provider portal, Claims platform, Excel/Google Sheets, Fax/email queues, Home-grown dashboards, Third-party care platform, Other
      • Describe one recent day-in-the-life moment that best captures the friction your care team faces (brief story)

      Are You Losing Ground Without Realizing It?

      • When you saw a 15% rise in avoidable ED visits, what did you most fear was silently failing in your program? Options: Risk stratification, Timely outreach/contacts, Transition-of-care follow-up, Data timeliness/alerts, Clinical protocol adherence, Other (please specify)
      • Over what time period did this increase emerge, and how consistent is the trend across lines of business? Options: Last 3 months, 3–6 months, 6–12 months, More than 12 months, Trend varies by line
      • Which member cohorts show the largest increase in avoidable ED use? Options: High-acuity chronic (e.g., CHF, COPD), Behavioral health / SUD, Complex pediatric, Dual-eligible, Transition-of-care recently discharged, Not sure / mixed
      • Who internally first raised the alarm about the trend and what did they say was happening? (capture the narrative)
      • How long have you tolerated these outcomes before treating it as an emergency? Options: We acted immediately, Within weeks, A few months, Over a year, Only now addressed due to audit/RFP pressure

      What's Burning for Your Care Teams Right Now?

      • If a nurse could wipe one task from their day, what would it be—and how would that extra time be used to prevent avoidable ED visits?
      • Approximately how many minutes per day does a care manager spend on documentation vs. direct member outreach? Options: <60 mins documentation / >240 outreach, 60–120 mins documentation / 120–240 outreach, 120–240 mins documentation / 60–120 outreach, >240 mins documentation / <60 outreach, Don't have precise split
      • Which manual tasks cause the most context-switching or missed follow-ups? (select up to 3) Options: Faxing referrals, Claims reconciliation, ADT alert triage, Manual appointment scheduling, Social needs referral tracking, Duplicate documentation across systems, Other
      • Tell us about a recent patient case where care team workload or tooling directly led to a missed intervention (what happened, impact)
      • How do care managers describe their level of burnout or frustration on a typical day? Options: Severe burnout, High stress but managing, Moderate frustration, Generally OK, Unsure / not asked

      How Do You Define Success — And Where Might We Be Blind?

      • If finance demands measurable PMPM savings within 12 months, what reduction feels realistic to you and why might that expectation miss the true value? Options: >10% PMPM, 5–10% PMPM, 1–5% PMPM, Target is unclear, Value likely in quality metrics more than PMPM
      • Which success signals are most persuasive for your executive team? (select top 2) Options: Avoidable ED visits, PMPM cost reduction, NCQA readiness/compliance, 30/60/90 day readmission reduction, Care manager capacity/utilization, Member experience/satisfaction
      • What baselines do you currently have for those signals, and how confident are you in their accuracy? Options: Strong, reliable baselines, Reasonable but some gaps, Partial data only, No reliable baselines, Unsure
      • What attribution window would you consider credible for showing impact on ED visits or PMPM (and why)? Options: 30 days, 60 days, 90 days, 6 months, 12 months
      • Who must sign off on success before you consider a pilot 'validated' (list roles and one requirement each)?

      Where Does Data Break Down (And Who Owns the Fix)?

      • Which single data gap causes the most missed interventions today? Options: ADT latency, Missing SDOH data, Delayed claims, Incomplete med lists/pharmacy, Inconsistent provider notes, Consent/access/legal restrictions
      • Which data sources are you able to ingest reliably today? (select all that apply) Options: Real-time ADT, Pharmacy claims, Medical claims, Laboratory results, SDOH screenings, Provider EHR notes, State HIE feeds, None/limited
      • How often do data delays or mismatches create a demonstrable missed outreach opportunity? Options: Daily, Weekly, Monthly, Rarely, Don't track
      • Who in your organization is responsible for resolving integration failures or data mapping issues? Options: IT / Integration team, Vendor/third-party integrator, Data analytics/BI, Clinical informatics, Shared responsibility, No clear owner
      • Describe a specific incident where a data gap led to an avoidable ED visit or audit exposure (what data, what went wrong)

      If We Could Fix One Workflow Today, Which Would Move the Needle?

      • Which single workflow change would free the most nursing time and reduce avoidable ED visits? Options: Automated ADT triage + tasks, Unified clinician workspace, Automated SDOH referrals, Risk-stratified outreach cadence, Medication reconciliation automation, Other (please specify)
      • For the workflow you chose, who is the primary owner today and who will own it after improvement? Options: Nurse care managers, Clinical supervisors, Population health team, IT/Analytics, Vendor partner, Other
      • Outline the typical steps in that workflow and where failures most commonly occur (brief)
      • Which patient cohort would you pilot this workflow on first? Options: Highest-utilizers (top 1%), High-acuity chronic conditions, Post-discharge within 7 days, Behavioral health with comorbidities, Dual-eligible, Other
      • What immediate, measurable acceptance criteria would convince you the workflow is working? Options: Reduction in ED visits for cohort, Increased completed outreach rate, Improved documentation time saved, Improved NCQA checklist items, Other

      Partnership Rules: What Would Truly De‑Risk This Rollout?

      • What specific data access commitments would you need from a vendor to feel comfortable starting a pilot? Options: Full ADT feed access, Claims file access (daily/weekly), Direct EHR read/CCDA, SDOH screening feeds, Role-based test accounts, Other
      • Which legal or compliance constraints are immediate blockers (e.g., state PHI rules, data residency, consent)? Options: State PHI variations, Consent management gaps, Data residency/hosting, Audit trail requirements, None obvious, Other
      • What SLAs or uptime commitments would be non‑negotiable for critical feeds (ADT/claims)? Options: Near-real-time (<5 min), Hourly, Daily, Batch weekly, Not sure—need guidance
      • How would you prefer governance to be structured during pilot and scale (roles, cadences)? Options: Weekly steering + ops, Biweekly review + escalation, Monthly exec review, Ad-hoc as issues arise, Other
      • What resources (FTE hours, technical support, clinical time) can you commit during the first 90 days? Options: Minimal (10–20 hrs/wk), Moderate (20–50 hrs/wk), Substantial (>50 hrs/wk), Unsure—need internal check

      What's the Real Roadblock to Change?

      • When procurement conversations start, what single objection typically kills momentum? Options: Budget constraints, Security/compliance concerns, Integration complexity, Clinical adoption risk, Lack of leadership buy-in, Other
      • Who are the decisive stakeholders in an RFP or procurement vote, and what is each most worried about?
      • What is your typical procurement timeline from RFP to contract signature? Options: <3 months, 3–6 months, 6–9 months, 9–12 months, >12 months
      • What internal change management or training capacity do you have to drive clinician adoption? Options: Dedicated training team, Clinical champions only, Shared across teams, Limited/no capacity, Unsure
      • Share an example where a technically viable solution failed because clinicians wouldn't change behavior—what happened and why?

      How Will We Validate — What Counts as Proof?

      • If the platform reduced ED visits by 10% for your pilot cohort, who needs to see which data to believe it's real? Options: VP Care Mgmt (trend reports), CIO (technical logs/feeds), Finance (PMPM calculations), CMO (clinical audit), QA/compliance (NCQA evidence)
      • What formal end‑to‑end tests with live data do you require before accepting a pilot result? Options: ADT alert to task creation, Claims ingestion to risk score update, SDOH referral flow to closure, Clinician workflow simulation with live notes, All of the above, Other
      • What sample size and time window would you consider statistically and operationally persuasive for pilot outcomes? Options: Small cohort, rapid signals (n<500, 30–60 days), Moderate cohort (500–5,000, 90 days), Large cohort (>5,000, 6–12 months), Depends on metric
      • Which dashboards or reports must be available at pilot close to support stakeholder sign‑off? Options: ED visits trend by cohort, PMPM cost delta, Completed outreach rates, NCQA readiness checklist, Clinician time-saved reports, All of the above
      • What would be your minimum acceptance criteria for moving from pilot to phased rollout? Options: Predefined % reduction in ED visits, Predefined % increase in completed outreach, Positive ROI within 12 months, NCQA audit items met, Combination of metrics

      Commitment & Next Steps — Are You Ready to Try Something Different?

      • Reflecting on this conversation, how ready is your organization to commit to a 90-day pilot focused on one high-acuity cohort? Options: Ready now, Ready with minor approvals, Need internal alignment (weeks), Not ready this quarter, Unsure
      • Who are the three people we should include in the pilot kickoff to avoid surprises, and what is each person's must-have outcome?
      • Which patient cohort would you prefer to target for an initial pilot (name and approximate size)?
      • What communication channel and cadence do you prefer for pilot updates? Options: Weekly email + monthly review, Weekly stand-up calls, Biweekly dashboard reports, Ad-hoc as issues arise, Other
      • What is your single biggest remaining concern about starting a pilot with our platform?
  7. Success

    Review outcomes vs. success signals, document learnings, and maintain a shared channel for issues and enhancements.

    Success Reviews

    • Outcome Validation Review
    • Data Attribution & Forensics
    • Clinical Effectiveness Retrospective
    • Lessons Learned, Backlog Prioritization & Experiment Roadmap
    • Governance, Shared Channel & Escalation Handoff

    Issues & Enhancements

    • Create prioritized backlog entries with acceptance criteria and estimated effort in the agreed tracker.
    • Agree on a re-run schedule and acceptance criteria for corrected measurements.
    • Provide ETL logs and a table-level completeness report for the review team within 48 hours.
    • Implement agreed ETL or mapping fixes and reprocess affected windows, then deliver updated results.
    • Document and version-control the final cohort definitions and measurement SQL/logic for audit readiness.
    • One-Sentence Future State Reminder
    • Surface top clinician-identified barriers and confirm which are platform vs operational (staffing/training) issues.
    • Identify specific protocol or workflow changes likely to improve outcomes and pilot plans.
    • Agree on a focused re-training plan or job-aid distribution for care teams.
    • Document top 5 clinician pain points with supporting examples and proposed mitigation steps.
    • Create and schedule targeted re-training sessions and job-aids for identified workflow changes.
    • Set up a small pilot for any protocol adjustments and define success criteria and duration.
    • Synthesis of Findings
    • Produce a prioritized backlog of enhancements and experiments directly tied to outcome improvements.
    • Define clear experiment plans with success criteria and owners for top-priority items.
    • Agree on a cadence for status reporting and experiment evaluation.
    • Welcome & Objective Alignment
    • Assign experiment owners and schedule pilot start dates with measurement plans.
    • Publish the improvement roadmap and circulate to stakeholders for transparency.
    • Agree Shared Channel & Access Controls
    • Create and provision a shared communication channel with clear access and channel taxonomy.
    • Agree on SLA targets, severity levels, and escalation paths for issues impacting outcomes.
    • Establish a recurring governance cadence and reporting pack for ongoing oversight.
    • Create the shared channel, invite required stakeholders, and post the governance doc and channel usage guidelines.
    • Publish the SLA definitions, severity matrix, and contact list for on-call rotations.
    • Schedule recurring governance meetings (weekly ops, monthly exec) and attach the first reporting deliverable.
    • Confirm whether each success signal is met, partially met, or unmet.
    • Ensure stakeholders accept the measurement methodology and attribution logic or request a forensic review.
    • Agree on a decision: sign-off, re-baseline, or initiate corrective action plan with owners and timelines.
    • Document the immediate business consequences of outcome gaps for finance and compliance stakeholders.
    • Produce and circulate a validated outcome report with charts, cohort definitions, and raw datasets for audit.
    • If metrics are disputed, schedule a Data Attribution & Forensics meeting within 5 business days.
    • Assign owners to corrective actions or re-baselining tasks with due dates and reporting expectations.
    • Pre-work Review & Evidence Checklist
    • Confirm integrity and completeness of each data feed used in outcome measurement.
    • Validate or correct attribution windows and cohort logic to ensure fair measurement.
    • Produce a remediation plan with owners and timelines for any identified data issues.
    • Define Roles, Responsibilities & RACI
    • Capture Improvement Opportunities
    • Current State (One Sentence)
    • Adoption & Usage Metrics
    • Data Feed & ETL Verification
    • Clinician Feedback & Pain Points
    • Attribution Window & Cohort Logic
    • SLA & Response Times
    • Impact vs Effort Prioritization
    • Outcome Dashboard Review
    • Reporting Cadence & Dashboards
    • Consequence & Business Impact
    • Case Studies: Wins & Misses
    • Define Experiments & Acceptance Criteria
    • Reconciliation of Discrepancies
    • Protocol Adherence & Adjustment Discussion
    • Discrepancies & Hypotheses
    • Statistical Significance & Baseline Stability
    • Roadmap & Owner Assignment
    • Change Request & Prioritization Process
    • Training / Change Management Actions
    • Final Sign-off & Communication Plan
    • Remediation Plan for Data Issues
First-Party AI

1-2 minutes please — Your AI agent is working

First-Party AI™ can make mistakes. Always check important information.